Dov Elefant serves as Executive at Cellectar Biosciences, Inc., where they oversee executive responsibilities. Since joining the company, Dov Elefant has executed 4 insider transactions totaling $15.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Aug 27, 2025 involved transacting 38,828 shares valued at $0.
Dov Elefant currently holds 58,436 shares of Cellectar Biosciences, Inc. (CLRB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Dov Elefant has been a net buyer of CLRB stock. They have purchased $15.0K and sold $0 worth of shares.
Dov Elefant's most recent insider trade was on Aug 27, 2025, when they sold 38,828 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $1.35 |
| Discretionary |
| Jun 5, 2020 | CLRB | $5.0K | Purchase | 4,348 | $1.15 | Discretionary |
| Feb 3, 2020 | CLRB | $27.1K | Award | 10,000 | $2.71 | Discretionary |